Disease Related Glycosylation Changes and Biomarker Discovery: Challenges and Possibilities in an Emerging Field

Published Special Issues
1 January 2008
30 May 2024

This issue is now published.

Editors

Guest Editors

Pauline M. Rudd1

1NIBRT Dublin Oxford Glycobiology Laboratory, NIBRT - The National Institute for Bioprocessing Research & Training, Ireland

Export Citation(s)Download PDF(s)

Article
Open Access

Glycosylation of Serum Proteins in Inflammatory Diseases

Olga Gornik,  Gordan Lauc, 
Article
Open Access

Fucosylated Glycoproteins as Markers of Liver Disease

Anand Mehta,  Timothy M. Block, 
Article
Open Access

Glycomic Approach for Potential Biomarkers on Prostate Cancer: Profiling of N-Linked Glycans in Human Sera and pRNS Cell Lines

Maria Lorna A. de Leoz,  Hyun Joo An,  Scott Kronewitter,  Jaehan Kim,  Sean Beecroft,  Ruth Vinall,  Suzanne Miyamoto,  Ralph de Vere White,  Kit S. Lam,  Carlito Lebrilla, 
Article
Open Access

Carbohydrate Markers in Colon Carcinoma

Sławomir Dariusz Szajda,  Anna Jankowska,  Krzysztof Zwierz, 
Article
Open Access

Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease Pathogenesis

Radka Saldova,  Mark R. Wormald,  Raymond A. Dwek,  Pauline M. Rudd, 
Article
Open Access

Altered Glycosylation in Tumours Focused to Cancer Diagnosis

Rosa Peracaula,  Sílvia Barrabés,  Ariadna Sarrats,  Pauline M. Rudd,  Rafael de Llorens, 
Article
Open Access

Glyco-biomarkers: Potential Determinants of Cellular Physiology and Pathology

Azita Alavi,  John S. Axford, 
Open Access

Editorial

Marion Boland,  Pauline M. Rudd,